Remove Government Remove Regulations Remove Treatment
article thumbnail

New Methadone Regulations Go Into Effect Oct. 2 2024

Common Sense for Drug Policy Blog

New regulations governing methadone treatment for opioid use disorder go into effect in the US on October 2, 2024. As reported by the Associated Press on Sept. 20, 2024 ("US will let more people take methadone at home"):

article thumbnail

Environmental, Social and Governance (ESG) and Climate Risk Investing – You must be kidding me?!

Perficient: Drug Development

Social factors consider a company’s treatment of employees, diversity and inclusion practices, community relations, and involvement in socially responsible initiatives. Governance factors focus on the organization’s leadership, transparency, accountability, and adherence to ethical business practices.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK Spring Budget a ‘vote of confidence’ in UK life sciences

Drug Discovery World

Additionally, a pledge to reform the regulation and approval of medicines, could see rapid approval for companies whose products have already gone through the US or European system and quickly open the UK as a new market.” We need regulation – but we need regulation that is focused on enabling solutions.”

Science 243
article thumbnail

UK life sciences can lead the way in cannabinoid R&D, says report

Drug Discovery World

The report suggests the UK can build on the success of GW Pharmaceuticals, whose multiple sclerosis treatment product nabiximols was the first natural cannabis plant derivative to gain market approval in any country. The government should provide clear guidance that outlines the processes for developing botanical medicines in the UK.

Science 130
article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

In a statement, the EFPIA said AI will have an ever more critical role in the research, development and manufacturing of medicinal products, allowing the discovery, development and delivery of new, safer, more effective treatments to patients faster than ever before.

article thumbnail

Turning Science into Business: Commercialising CRISPR

Drug Discovery World

MP : We currently develop CRISPR based molecular tools for clients creating new therapies for the treatment of various diseases, but we also work in diagnostics and agriculture. As an example, we work with Spanish company Integra Therapeutics, combining their technology with ours to develop a therapeutic treatment approach.

Science 263
article thumbnail

NHS England launches country-wide cancer vaccine trials

Drug Discovery World

Thousands of cancer patients in England are set to gain fast-tracked access to trials of mRNA personalised cancer vaccines following the launch of an NHS trial ‘matchmaking’ service to help find new life-saving treatments.

Vaccine 147